NCT03243474 is a clinical trial in Atrial Fibrillation, sponsored by Kardio-Med Silesia.

Who is sponsoring NCT03243474?

NCT03243474 is sponsored by Kardio-Med Silesia.

What condition does NCT03243474 study?

NCT03243474 studies Atrial Fibrillation.

Is NCT03243474 still recruiting?

NCT03243474 is currently completed. Last updated 2 April 2019.

Last reviewed 2019-04-02 · How we verify

NCT03243474

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Non-invasive Monitoring for Early Detection of Atrial Fibrillation

Completed Last updated 2 April 2019

What this trial tests

trial in Atrial Fibrillation in 3,014 participants. Completed in 10 March 2019.

Timeline

15 March 2017

Primary endpoint
10 March 2018

10 March 2019

Quick facts

Lead sponsor	Kardio-Med Silesia
Status	Completed
Study type	OBSERVATIONAL
Enrollment	3,014
Start date	15 March 2017
Primary completion	10 March 2018
Estimated completion	10 March 2019
Sites	7 locations across Poland

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

Kardio-Med Silesia

Who can join

Adults 65 to 110, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this project is to recognize the actual frequency of atrial fibrillation in the Polish population as well as to determine the independent risk factors for the occurrence of its clinically symptomatic and asymptomatic forms

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study.
Gumprecht J, Lip GYH, Sokal A, Średniawa B, et al · · 2021 · cited 21× · PMID 34167520 · DOI 10.1186/s12933-021-01318-2
Cardiac Electronic Devices: Future Directions and Challenges.
Kotalczyk A, Kalarus Z, Wright DJ, Boriani G, et al · · 2020 · cited 18× · PMID 33061681 · DOI 10.2147/mder.s245625
Predicting Silent Atrial Fibrillation in the Elderly: A Report from the NOMED-AF Cross-Sectional Study.
Mitrega K, Lip GYH, Sredniawa B, Sokal A, et al · · 2021 · cited 10× · PMID 34073411 · DOI 10.3390/jcm10112321
Wear Your Heart on Your Sleeve: Smart Textile ECG Wearables for Comfort, Integration, Signal Quality and Continuous Monitoring in Paroxysmal Atrial Fibrillation.
Avanu AE, Dodi G. · · 2025 · cited 2× · PMID 39943314 · DOI 10.3390/s25030676
Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence in the Polish population aged ≥ 65.
Gumprecht J, Lip GYH, Sokal A, Średniawa B, et al · · 2023 · cited 1× · PMID 37828071 · DOI 10.1038/s41598-023-43939-5
The Usefulness of Outpatient Cardiac Telemetry in Patients with Cryptogenic Stroke
Lasek-Bal A, Konka A, Puz P, Boidol J, et al · · 2024
Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence. A report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study
Gumprecht J, Lip GYH, Sokal A, Średniawa B, et al · · 2023 · DOI 10.21203/rs.3.rs-2517000/v1
Relationship Between Diabetes Mellitus and Atrial Fibrillation Prevalence in the Polish Population. A Report From the Non-Invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) Prospective Cross-Sectional Observational Study
Gumprecht JJ, Lip GY, Sokal A, Średniawa B, et al · · 2021 · DOI 10.21203/rs.3.rs-443959/v1

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03243474 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kardio-Med Silesia
Last refreshed: 2 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03243474.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing